Latest News
OmniAb, Inc.
- OmniAb notes China NMPA approval of batoclimab through partners for generalized myasthenia gravis
- OmniAb at LD Micro main event: royalties, scale and patience
- OmniAb to Report Third Quarter 2026 Financial Results on October 30
- OmniAb Q3FY26 Results: Earnings call set for October 30
- OmniAb to Report Third Quarter 2026 Financial Results on October 30
- OmniAb Leads The Pack Of 3 Intriguing Penny Stocks
- Leerink Partners Sticks to Its Buy Rating for OmniAb (OABI)
- Stifel reiterates OmniAb stock rating on technology platform By Investing.com
- OmniAb Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares - Profit Recovery Report
Headlines from the last 30 days, linking to the original publishers. See all market news →